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Properties ofIsolated Gastric Enterochromaffin-like Cells
Ningxin Zeng and George Sachsa
Wadsworth VeteransAdministration Hospital and UCLA, LosAngeles, California
The gastric enterochromaffin-like cell (ECL) has been studied in gastric fundic
glands byconfocal microscopy andas apurified cell preparationby videoimaging
ofcalcium signaling and measurements ofhistaminerelease. Regulation ofgastric
acid secretion is largely due to alterations of histamine activation of the H2
receptor on the parietal cell and can be divided into central neural regulation,
withdirect actions ofneuronallyreleasedmediators andintoperipheralregulation
by substances released from other endocrine cells. Gastric neuronal stimulation
of acid secretion by alteration of ECL cell function is probably mediated by
pituitary adenylate cyclase activating peptide (PACAP) receptors on the ECL
cell, which activate calcium signaling and histamine release. Peripheral stimula-
tion ofacid secretion via the ECLcell is largely mediated by gastrin stimulation
ofcalcium signaling and histamine release. Gastric neuronal inhibition ofECL
cell function is probably mediated by galanin inhibition of calcium signaling,
and histamine release and peripheral inhibition of ECL cell function is mainly
due to somatostatin release from D cells.
INTRODUCTION
Acid secretion and its regulation has been a subject ofintense investigation formost of
this century. Until about 10years ago, mostphysiciansbelieveddevoutlythatpeptic ulcerdis-
ease wasuniquely related toacid secretion.Alltherapies were, therefore, focussed oninhibition
ofacid secretion. Early investigations, therefore, concentratedonregulation ofacid secretion,
perhaps stimulatedby Pavlov's seminal observations on the cephalic phase ofacid secretion
in his trained Russian dogs in the last decade ofthe nineteenth century, perhaps inspired by
the perceived medical need to inhibit acid secretion as a part ofa therapeutic regimen [1-3].
Stimulation ofacid secretion was divided into acentral orcephalic phase, as envisioned
by Pavlov, and aperipheral phase, as determinedbyinjection ofaputative regulator ofacid
secretion. The central phase results from stimulation of vagal outflow from the central
nervous system andpost-ganglionic release ofneurotransmitters within the gastric epithelium,
the peripheral phase from exoctytotic events in gastric or intestinal endocrine cells. The
central post-ganglionic pathway must converge on eitherthe gastric endocrine cells or the
parietal cell or both. Therefore, a definition ofneurally mediated regulation is alteration in
secretion due to a direct effect ofsubstances released from gastric nerves; peripheral regula-
tionderivesfromalteration in secretionduetosubstances releasedfromendocrinecells [1,4,5].
At the turn of the century, Edkins discovered gastrin [6], Loewi discovered acetyl-
choline [7] andDale histamine [8]. Sobythe 1920s, manyoftheperipheral secretagogues that
are cited today had been described although it was to take half a century for the idea of
gastrin tobeaccepted.Then, ironically, thegastrinologists discounted anyroleforhistamine.
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Also, over the next halfcentury, therapeutic inhibition ofacid secretion rested largely
with the skilled hands of surgeons progressing from gastrectomy to highly selective vago-
tomy. Then, the synthesis of selective H2 receptor antagonists not only provided the first
effective and tolerated medication for acid inhibition but disproved the position taken by
most of the researchers working on gastrin [9]. Cimetidine established histamine as a
prominent player in regulation ofacid secretion in the human stomach [9]. The source of
gastric histamine became a topic ofdispute. Were mast cells indeed the answer? Or were
the enterochromaffin-like (ECL)b cells responsible? Was the ECL cell the sole source or
was there a mixed cell population giving rise to histamine?
Whereas stimulants ofacid secretion that were discovered early in gastric physiology,
knowledge of the physiological inhibitors ofacid secretion lagged behind. The molecules
turned out to be peptides with shortplasmahalflives, such as somatostatin. Improvements
in separation technology provided a list of possible peptide inhibitors. Still today, the
word "enterogastrone" hides a fundamental ignorance as to the substances involved in the
decrease ofacid secretion during the intestinal phase ofdigestion. From laboratories expe-
riencedinpeptideisolation and separationtechniques, anumber notonlyofpeptideantagonists
but additional peptide agonists ofgastric secretion was discovered [2, 10-18].
Due to this effort, a long list ofpossible substances emerged as modifying acid secre-
tion. With the advent of molecular biology, it became possible to find the structure ofthe
receptors for these substances [19-22]. Then techniques such as in situ hybridization,
immuno-staining and RT/PCR ofRNA isolated from purified cells elucidated the location
of many receptors [22-24]. They are to date, almost without exception, present in more
than one cell type in the gastric mucosa. The physiological interactions ofthese are therefore
difficult to define in vivo. For example, an agonist able to release both stimulatory and
inhibitory factors from different endocrine cells would have an unpredictable effect follow-
ing injection. The physiological role ofsuch an agonist may be determined by the location
of its release from peptidergic nerves or the presence of receptors of different selectivity
in activating and inhibitory endocrine cells. For this reason, there has been increasing
attention paid to less complicated models such as isolated gastric fundic glands or isolated
endocrine cells. In such preparations, it is easier to decide whether a stimulatory or
inhibitory action is exerted directly on the target cells, i.e., parietal cells, or whether an
effect is secondary to changes in function of a specific endocrine cell. In this review, we
shall focus on data derived from these in vitro models ofregulation ofgastric acid secretion
focusing on the role ofthe ECL cell in regulation of gastric acid secretion.
ECL CELL IN FUNDIC GLANDS
Functional isolated gastric glands were first produced from the rabbit [25]. Essential
to the success ofthis model was the ability to measure acid secretion. Since the secretory
canaliculus ofthe parietal cell, and the lumen ofthe isolated gland is essentially a closed
space, acid secretion was measured using the accumulation ofthe weakbase, aminopyrine.
Its pKa of 4.0 allowed selective assessment of parietal cell acidity since other acidic
spaces have a pH greater than 4.0.
This model responded well to histamine and dbcAMP. There was also a response to
carbachol, but this was transient. The basis of the transient nature of this response still
remains unexplained. The response to gastrin was weaker than to either histamine or carba-
chol and was ablated either by H2 blockade by cimetidine or by the presence of diamine
oxidase in the medium [26-31]. These latter data were explained as showing that theparietal
cell response to gastrin was indirect, dependent on the release ofhistamine from enterochro-
maffin-like cells still present in the isolated gland. In vivo data measuring rat gastric acid
secretion also showed that whereas carbachol stimulation could be only partially affected
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by the presence of a H2 receptor antagonist, gastrin stimulation was completely blocked
[5, 32]. Similar data were also obtained for humans. The isolated rabbit gland data were,
therefore, pharmacologically equivalent to the in vivo data.
The isolation and sequencing ofthe gastrin receptor from a parietal cell library along
with binding studies proved the presence ofagastrin (CCK-B) receptor on theparietal cell
[33]. There was also in vivo evidence that there was potentiation between gastrin and car-
bachol orgastrin andhistamine [32]. Thisclusterofdata was naturallyinterpreted asevidence
for a functional gastrin receptor on the parietal cell capable ofindependent stimulation of
acid secretion. It had been shown that gastrin was able to elevate [Ca]in in isolated parietal
cell suspensions, proving the presence ofa functional CCK-B receptor on the parietal cell
correlating withthe sequencing andbinding studies [26,27]. Howdidthose datajibe withthe
histamine dependence ofgastrin's effect as determinedby H2 blockade in vivo and in vitro?
Interaction ofgastrin with the ECLcell and stimulation ofhistamine release from that
cell type and stimulation ofsecretion by carbachol using different pathways could explain
the potentiation seen between gastrin and carbachol. The potentiation between histamine
and gastrin was more difficult to understand given thatgastrin had to release histamine for
stimulation of gastric secretion. However, it was shown that effective stimulation of acid
secretionby gastrin (andcarbachol) in isolated ratandpig parietal cells required thepresence
of cAMP [27]. Since histamine elevates cAMP in the parietal cell (and to a minor extent
[Ca]in), gastrin's elevation ofacid secretion might well depend on elevation ofcAMP, par-
ticularly ifcAMP-dependent protein kinase phosphorylated a critical protein in the stimula-
tory cascade deriving from gastrin's binding to the CCK-B receptor. Then, in the absence
of cAMP elevation, there would be no effect of gastrin on acid secretion. Superfusion of
isolated gastric glands with gastrin generated a calcium signal simultaneously in the ECL
cell (defined by histamine autofluorescence) and the parietal cell (defined by shape and
location). Cimetidine abolished the parietal cell effect, but this was restoredby the addition
ofdbcAMP. Even the calcium response in the parietal cell due to gastrin depended on eleva-
tion of cAMP either by histamine or by addition of dbcAMP. No such dependence was
observed for the calcium signal generated by gastrin in the ECL cell. It can, therefore, be
argued that cAMP elevation is essential for any effect of gastrin on the parietal cell.
Elevation ofcAMP in the parietal cell is consequently permissive for the action ofgastrin
on [Ca]in [27]. This fundic gastric gland model provided significant information on the
mechanism of action of gastrin, carbachol and histamine but has not been used further to
dissect out other ECL cell responses.
ENDOCRINE CELLS
There are at least three endocrine cells that play a major role in regulation of acid or
pepsinogen secretion, the enterochromaffin-like cell, the gastrin or G cell and somatostatin
or D cell. The ECL cell is found mainly in the fundic region of the stomach, the G cell in
the antral gland and the D cell in both the antral and fundic region. The fundic and antral D
cells may differ in some oftheir receptor properties, given that the antral D cell communi-
cates with the antral gland lumen and isjuxtaposed to the G cell and that the fundic D cell
does not communicate with the gland lumen and is in the vicinity ofthe ECLcell [34, 35].
We now have considerable knowledge of the major cell types of the gastric mucosa,
namely the parietal cell and the chiefcell. Their function (acid and pepsinogen secretion)
is relatively easy to measure in vivo and in vitro, and functional assay therefore permits a
definition of the responsive elements in these cells. Purification of these secretory cells
starts out with 30 percent of the cell population. Purification of the major endocrine cells
ofthe mucosa is more troublesome, since each type represents not more than one percent
of the cell population. Identification of the cell that has been enriched or purified is also
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Figure 1. General methodology for purification of ECL cells and enrichment for ECL and
other endocrine.
more difficult since there are multiple ligands producing different end effects. Many of
these self-same ligands can also be released into the medium bathing a mixed endocrine
cell population generating secondary effects. In order to identify explicitly each receptor
present on a single cell type, various strategies can be used. Cells can be obtained at high
purity (over 90 percent), neutralizing antibodies against possible contaminating ligands
can be added to the suspension medium and superfusion usedduring video imaging ofcalcium
signaling in individual cells in apopulation. When this method is combined with immuno-
staining, it is possible to identify different endocrine cell types by their characteristic lig-
and responses [36]. The general methods we have applied to endocrine cell purification or
enrichment are shown in Figure 1.
Table 1. An abbreviated list ofagonists or other agents that have been shown or postulated to
react with one or other ofthe cells ofthe gastric mucosa.
Cell Type
Receptor ECL G D Parietal Chief
CCK-A No No Yes No Yes
CCK-B Yes No Yes Yes No
PACAP Yes ? VIP ? Yes
M1,3,5 Yes Yes No Yes Yes
M2,4 No No Yes No No
GRP No Yes Some ? ?
ST Yes Yes Yes Yes Yes
Ca ? Yes ? ? ?
Yl Yes ? ? ? ?
GAL Yes ? ? ? ?
Histamine H3/H1 No H3 H2 Species
CGRP No No Perhaps No No
Amino acids No Perhaps No No No
pH No Perhaps Perhaps No No
In some instances, where effects have been described only on incubation with mixed cell popula-
tions, a question remains as to the target of these agonists or antagonists. Boldface type indicates
clear significance of the receptor in target cell function. Where direct effects have not been shown,
but only release studies, a question mark is put in the table.
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Work to date measuring calcium signaling on five types of gastric epithelial cells in
avariety ofpreparations is summarized inTable 1. Evidently there is significant cross-talk
between the different cells of the gastric epithelium but the importance of histamine in
regulation of acid secretion places regulation of the ECL cell as the most important cell
controlling gastric acid secretion.
The large number ofligands that regulate secretory function ofthe gastric epithelium
speaks to the delicate adjustment ofthe rate ofacid secretion that occurs in order to tailor
the response to meet the demand placed on the stomach by the quantity and quality ofthe
meal. We shall however discuss only the ECL cell here, since it is the only gastric
endocrine cell that we have available in high purity, making superfusion and histamine
release data alike in their interpretation.
ECL CELL
The ECL cells produce and store histamine [37]. This biogenic amine is stored in
vesicles to give a total content of2.8 to 4.3 pg/cell ofhistamine, which is a relatively low
amount compared to mast cells (12 to 20 pg/cell). As for other gastric endocrine cells, this is
a small, about 10 um diameter, cell found at mostly towards the base ofthe fundic gastric
gland. It contains acidic vacuoles with an eccentric electron dense spot [38]. Renewed
interest in this cell was generated by the finding that high doses ofomeprazole resulted in
ECL cell hyperplasia and carcinoid formation in rats [39-41].
There are various means ofidentifying this cell type. Under fluorescence microscopy,
the vacuoles accumulate acridine orange due to theiracidity, resulting in aredfluorescence
characteristic ofacid spaces. The cells express histidine decarboxylase requiredforhistamine
biosynthesis [42]. Because they contain vacuoles rather than granules (such as G and D
cells), they are somewhat less dense andcanbepurified almostto homogeneity from agas-
tric epithelial cell suspension. Acombination ofelutriation (to select a small cellpopulation)
and Nykodenz gradient centrifugation produces an ECL enriched population (about 70
percent). Forty-eight hour culture in growth medium results in a cell population containing
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Figure 2. The various receptors of the gastric ECL cell shown to affect calcium signaling
and/or histamine release.
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about 90 percent ECL cells. A large number ofreceptors present on the ECLcell have been
identified directly, by video imaging of calcium signaling, by PCR of an ECL cell cDNA
library orRT/PCR of RNA isolated from ECL cells and also by measurements ofhistamine
release from an approximately 90 percent pure population of these cells [43, 44]. Several
recent reviews are available [34, 45, 46]. These receptors are summarized in Figure 2.
STIMULATION OF ECL CELLS
Peripheral
The major stimulatory ligand for histamine release from these cells is gastrin.
Addition of gastrin to a perfusate results in a characteristic biphasic increase in intracel-
lular calcium for stimulation by pituitary adenylate cyclase activating peptide (PACAP).
The initial spike is due to release of calcium from intracellular stores, the steady state due
to entry of calcium from the medium.
Essentially all ECL cells respond to gastrin with a similar elevation of [Ca2+]i The
EC50 for gastrin for both the calcium signal and histamine release is about 10-10 M. The
elevation ofsteady state calcium is essential for release ofhistamine and is due to activation
of receptor operated calcium channels (ROCC) by gastrin.
The ECLcell also has voltage-dependent calcium channels (VDCC). The depolarization
ofthe ECLcell by the addition of40 mM K+ or 20 mM tetraethyl amine, results in a calcium
signal that is inhibited by calcium channel blockers such as nifedepine or o-conotoxin at
appropriately low concentrations. The addition ofthe L channel activator, Bay K8644 also
results in abiphasic elevation ofintracellular calcium. This shows the presence ofnot only
receptor operated calcium channels but also of depolarization activated or voltage depen-
dent calcium channels in the ECL cell, channels similar to those found in other neuroen-
docrine cells [47].
These VDCCs could be activated during exocytosis due to electrical changes following
fusion of the histamine containing vacuole with the plasma membrane of this cell. The
histamine containing vacuole membrane has a V-type ATPase that is an electrogenic proton
pump. Acidification by this pump depends on the presence of a chloride conductance that
allows electrogenic proton pumping. Accumulation ofhistamine is driven by a histamine-
proton counter-transport mechanism as found in other amine transporting vacuoles [48].
Whole cell patch clamp experiments have shown that the ECL cell has a resting voltage
of about -50 mV and a low membrane conductance. Depolarization was found to activate K+ channels that were Ba2+ inhibited. Stimulation of histamine release by gastrin resulted
in activation of a chloride current, presumably due to fusion of the vacuole membrane
with the plasma membrane [48]. The model ofexocytosis that ensues from these data suggests
that the chloride current derives from insertion ofthe Cl- channel present in the histamine
containing vacuole. The depolarization that would result from this could be counteracted
by the depolarization activated K+ channels but could also activate VDCCs. Hence, the
steady-state elevation of cell calcium by gastrin could be due to activation of both ROCC
and VDCC pathways
The pathway for gastrin stimulation ofparietal cell acid secretion is via CCK-B recep-
tor activation on the ECL cell with release of histamine and activation of the H2 receptor
on the parietal cell. This is consistent with the ablation of acid secretion due to pentagastrin
stimulation that is found with H2 receptor antagonists [27, 32]. It also explains the loss of
gastrin responsiveness when the ECL cell is unable to synthesize histamine due to the
addition of the histidine decarboxylase inhibitor, 5-a-fluoromethyl histamine [49].
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Central Stimulation
Carbachol also results in a biphasic increase of intracellular calcium perhaps due to
activation of a M, or a M3 receptor. mRNA for both has been found by RT/PCR, and
blockade by pirenzepine indicates afunctional M1 receptor [23, 24]. However, in the ECL
cell population, only about 10 to 20 percent ofthe cells respond [36]. The parietal cell also
has a M3 receptor [24], and from these data much ofthe vagal cholinergic response is due
to direct activation of the parietal cell. Cimetidine was relatively ineffective in inhibition
of carbachol-induced acid secretion, consistent with the distribution of these activating
muscarinic receptors in ECL and parietal cells.
PACAP is the most recent peptide found of the secretin/glucagon/VIP family [50]. It
is found in nerve fibers and is clearly a neurotransmitter. The PACAP receptor appears to
be linked to both cAMP and calcium elevation in a variety of cells. Forskolin activates
adenylate cyclase and is able to stimulate histamine release from ECL cells [43]. PACAP
is an effective and potent stimulant of elevation of intracellular calcium and ofhistamine
release from the in vitro ECL cell preparation. The EC50 for PACAP is about 10-9 M and
is about 1,000-fold less than for VIP.
The dose response to PACAPfor the calcium signal is similar to the dose response for
histaminerelease, whichalsoillustrates thatmostoftheECLcells arePACAPresponsive [51].
A surprising finding is that the injection of PACAP does not stimulate basal acid
secretion and even inhibits gastrin stimulated acid secretion. To explain this finding, it is
likely that the effect ofPACAP on the fundic D cell is dominant when PACAP is present
in the gastric circulation. PACAP has been shown to release somatostatin from D cells in
vitro [51] and injection of a neutralizing somatostatin antibody results in stimulation of
gastric acid when PACAP is injected [52]. Thus, the effect of PACAP on the ECL cell
found in vitro in the absence ofD cell stimulation corresponds to the effects ofPACAP in
vivo, provided that the effects of D cell stimulation are prevented. The effectiveness of
PACAP as an in vitro stimulant of ECL cell function indicates that it is likely to be the
central stimulant ofthe ECL cell.
Epinephrine also stimulates histamine release from ECL cells, as does the stimulant
of adenylate cyclase, forskolin. Previously obtained in vivo data suggest that this stimula-
tion may be mediated by activation of a 83 adrenergic receptor, but it is unclear as to the
physiological significance of this pathway of stimulation ofhistamine release [46].
There is, therefore, evidence for four activating receptors in the ECL cell population
isolated from rat gastric mucosa. The CCK-B and PACAPreceptors are likely to be dom-
inant in positive regulation of ECL function and, therefore, histamine dependent acid
secretion, as shown in Figure 2. Much ofcholinergic mediation ofacid secretion is due to
direct effects of acetylcholine on the parietal cell.
INHIBITION OF ECL CELLS
The setting of the rate of acid secretion to a specific level requires not only stimula-
tion of the ECL cell but also inhibition. Various inhibitors ofECL cell calcium signaling
and histamine release have been described. A partial list includes somatostatin, PYY,
galanin and even histamine. Two second messenger systems have been identified in ECL
cells. All of the activating receptors we have studied appear to have the ability to release
intracellular calcium and activate ROCC. In addition, depolarization ofthe cell with either
high K+ or by Bay K8644 also increases intracellular calcium levels. The action of
inhibitors of ECL cell function also is exerted against calcium signaling by this cell.
Inhibitors of ECL cell function apparently must inhibit calcium signaling.
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Peripheral
Somatostatin inhibits ECLcell function by binding at an SST subtype 2 receptor [52].
PCR of a cDNA library based on ECL cell mRNA showed that only the SSTR type 2 was
significantly enriched in ECL cDNA. Single cell video imaging of highly purified ECL
cells in culture demonstrated that only the SSTR type 2 selective agonist, DC 32-87,
inhibited the gastrin-induced calcium entry at concentrations reported to be selective for
this subtype (10-"IM). Type 3 and type 4 selective agonists, DC 25-12 and DC 32-92, and
also somatostatin SS-14 required 100 to 1000 times higher concentrations, namely 10-8
M. Similar results were obtained when the effects ofselective agonists on gastrin-induced
histamine release were studied [52]. The SSTR type 2 analog inhibited the gastrin-stimulated
histamine release with an IC50 of 2 x 10-12 M. Somatostatin SS-14 and the type 3 and 4
analogs showed IC50 values of 1-5 x10-9 M. The effect of somatostatin was abolished by
pre-incubation with pertussis toxin (PTX) showing that the SST 2 receptor in these cells
was coupled toGi or GO'
The proximity of the fundic D cell to the ECL cell suggests that the somatostatin
involved in ECL cell inhibition is released from the fundic, not the antral, D cell. Thus,
regulation ofthe fundic D cell is intimately involved in the peripheral regulation of ECL
cell function. Somatostatin is so far the most effective inhibitory ligand of ECL cell cal-
cium signaling and histamine release. It is the major candidate for the peripheral inhibitor
of histamine release and, therefore, acid secretion. Agonists of fundic D cells, therefore,
play an important role in the regulation of the ECL cell.
The peptide PYYis found in duodenal extracts and has a variety ofinhibitory actions.
Gastrin stimulated histamine release was partially inhibited by PYY with an IC50 of 2 x
10-9M. Inhibition ofhistamine release and ofcalcium entry by PYY and [Pro34]-PYY and
no effect of PYY [3-36] identifies the inhibitory receptor as being aY, receptor subtype.
RT-PCR of ECL cell RNA showed that the receptor was the non-truncated Y1 isoform.
The inhibitory action ofPYY and related peptides on gastrin stimulated histamine release
and calcium signaling was also abolished by pre-treatment with PTX at 200 ng/ml.
Additive but not synergistic inhibitory effects ofPYY and somatostatin on gastrin-stimulated
histamine release were observed. It is not clear, however, whether this concentration of
PYY is found in the vicinity of the ECL cell in vivo [53, 54].
Evidence from the intact stomach, and from isolated glands has shown that there is
an H3 histamine receptor subtype present with inhibitory pharmacological actions [43,
46]. In vivo studies previously suggested that histamine secretion and especially histamine
synthesis is under a feedback control of histamine. In the purified ECL cell preparation,
the H3 agonist, R-oc-methylhistamine is able to inhibit gastrin-stimulated histamine
release. The H3-antagonist, thioperamide, is able to activate histamine release. These data
suggest that there is a feedback loop to prevent excessive release of histamine by activation
ofthe H3 receptor on the ECL cell. There is additional evidence for an H1 receptor on this
cell type, but this would result in auto-activation of this rather toxic transmitter [45].
Central Neural
Galanin is a 29-amino acid neuropeptide initially identified in the porcine intestine
and now known to be widely distributed in peripheral and central neurons. In the periphery,
galanin colocalizes with other neuropeptides (VIP, NPY) in nerve cell bodies and fibers
of the myenteric plexus and submucosal plexus close to the mucosal epithelium mucosa
[57]. A recent study also showed that a galanin receptor(GALRI) was highly expressed
in human gastric mucosal biopsies indicating that a target for galanin was present in the
fundic mucosa [58]. A second galanin receptor has also been cloned (GALR2) [59]. The
former appears inhibitory, the latter was shown to elevate cell calcium when transfected
into cultured cells [60].
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Figure 3. The effect ofgalanin on basal andgastrin stimulated calciumsignaling in the ECLcell.
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Figure 6.Amodel ofneuronal and peripheral regulation ofgastric acid secretion by the major
receptors ofthe ECL cell.
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Table 2. A comparison ofthe properties ofthe various inhibitory ligands identified thus far in
perfusion studies ofthe isolated rat ECL cell.
Inhibitors ofECL cells
Gal PYY SS His3
R subtype Gal 1 Y1 SSTR2 H3
Ca/release Yes No Yes Yes
Ca/entry Yes Yes Yes Yes
Histamine/basal Yes No Yes ?
Histamine/stimulated Partial Partial Complete Complete
PTX sensitive Partial Complete Complete ?
Among its many actions, galanin has been shown to influence gastric acid output
[61]. A direct action on antral G cell has been suggested because galanin was found to
inhibit bombesin-stimulated gastric acid secretion in rats and dogs [62, 63]. Galanin inhibited
basal and GRP-stimulated gastrin release in isolated stomach preparations as well as gastrin
release from in vitro isolated rat G cells in primary culture [64]. Since it inhibits penta-
gastrin-stimulated and basal acid secretion [60] and an abundance of galanin immuno-
reactive nerve endings are found in fundic mucosa [57], galanin must act downstream of
the G cell perhaps directly on fundic ECL cells. No effect of galanin on somatostatin
release was found in vivo and in vitro, hence, somatostatin is not involved in the inhibitory
action ofgalanin [65, 66]. Because galanin had no inhibitory effect on bethanechol orhis-
tamine-stimulated gastric acid secretion, a direct inhibitory action of galanin on parietal
cell is also unlikely. Morphologically, gastric mucosal nerve terminals containing galanin
are found adjacent to ECL cells in gastric fundic mucosa [57].
The peptide was found to inhibit gastrin stimulated calcium signals in the ECL cell as
shown in Figure 3. Here 10 nM galanin reversibly blocked gastrin effects on ECLcell [Ca2+]i.
The peptide also partially (60 percent) inhibits histamine release from the ECL cell
with an EC50 of 1 x 10-10 M as shown in Figure 4.
The partial antagonist activity of galanin is due to a rapid desensitization of the
galanin receptor.
Two galanin receptors have been cloned. They can be distinguished by the use of
chimeric peptides containing the N-terminal sequence of galanin in combination with
other peptide sequences. Nested RT/PCR shows the presence of a gal 1 receptor subtype
as demonstrated in Figure 5. The actions of galantide, C7 and M40, with the first acting
as an antagonist and the latter two as partial agonists, suggest that the ECL cell gal 1
receptor has properties similar to the pancreatic galanin receptor.
Pretreatment with PTX greatly reduced the inhibitory action of galanin on basal and
stimulated histamine release as well as the inhibition ofCa2+ influx [561.
There are, therefore, a variety of inhibitory factors that influence calcium signaling
and histamine release from the ECLcell, ofvarying potencies and efficacies. The follow-
ing table summarizes their effects on calcium signaling and histamine release.
From this, and the relative efficacy of galanin and somatostatin, it is likely that
somatostatin is the majordown regulator ofECLcell function that is locally released. The
function ofPYY as a component ofenterogastrone is endocrine and the affinity ofthe Y1
receptor on the ECL cell for PYY is low compared to the affinity ofthe SST 2 receptor for
somatostatin. Under in vitro conditions, it is difficult, perhaps, to achieve histamine concen-
trations sufficient to inhibit calcium signaling and histamine release. The role of the H3
receptoris, therefore, still unclear. Galanin andgalanin 1 receptor are present in the stomach.
Galanin is, therefore, the only candidate identified thus far for central regulation ofECL
cell function.
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The role of the ECL cell in regulation of gastric acid secretion is, therefore, becom-
ing better understood as isolated cell and gland models have become available. In sum-
mary, a model of the ECL cell as describing central and peripheral regulation of parietal
cell acid secretion is shown in Figure 6. Here only the major regulatory receptors are
shown, where function has been demonstrated in all isolated ECL cells with correspond-
ing in vivo data.
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